Jaworska Joanna, Gravel Annie, Fink Karin, Grandvaux Nathalie, Flamand Louis
Rheumatology and Immunology Research Center, Room T1-49, 2705 Laurier Blvd., Quebec, Quebec, Canada G1V 4G2.
J Virol. 2007 Jun;81(11):5737-48. doi: 10.1128/JVI.02443-06. Epub 2007 Mar 21.
Human herpesviruses (HHV) are stealth pathogens possessing several decoy or immune system evasion mechanisms favoring their persistence within the infected host. Of these viruses, HHV-6 is among the most successful human parasites, establishing lifelong infections in nearly 100% of individuals around the world. To better understand this host-pathogen relationship, we determined whether HHV-6 could interfere with the development of the innate antiviral response by affecting interferon (IFN) biosynthesis. Using inducible cell lines and transient transfection assays, we have identified the immediate-early 1 (IE1) protein as a potent inhibitor of IFN-beta gene expression. IE1 proteins from both HHV-6 variants were capable of suppressing IFN-beta gene induction. IE1 prevents IFN-beta gene expression triggered by Sendai virus infection, double-stranded RNA (dsRNA) and dsDNA transfection, or the ectopic expression of IFN-beta gene activators such as retinoic inducible gene I protein, mitochondrial antiviral signaling protein, TBK-1, IkappaB kinase epsilon (IKKepsilon), and IFN regulatory factor 3 (IRF3). While the stability of IFN-beta mRNA is not affected, IE1-expressing cells have reduced levels of dimerized IRF3 and nucleus-translocated IRF3 in response to activation by TBK-1 or IKKepsilon. Using nuclear extracts and gel shift experiments, we could demonstrate that in the presence of IE1, IRF3 does not bind efficiently to the IFN-beta promoter sequence. Overall, these results indicate that the IE1 protein of HHV-6, one of the first viral proteins synthesized upon viral entry, is a potent suppressor of IFN-beta gene induction and likely contributes to favor the establishment of and successful infection of cells with this virus.
人类疱疹病毒(HHV)是具有多种诱饵或免疫系统逃避机制的隐匿性病原体,有利于它们在受感染宿主体内持续存在。在这些病毒中,HHV-6是最成功的人类寄生虫之一,在全球近100%的个体中建立终身感染。为了更好地理解这种宿主-病原体关系,我们确定HHV-6是否会通过影响干扰素(IFN)生物合成来干扰先天性抗病毒反应的发展。使用诱导性细胞系和瞬时转染试验,我们已确定立即早期1(IE1)蛋白是IFN-β基因表达的有效抑制剂。来自两种HHV-6变体的IE1蛋白均能够抑制IFN-β基因诱导。IE1可阻止由仙台病毒感染、双链RNA(dsRNA)和dsDNA转染或IFN-β基因激活剂(如视黄酸诱导基因I蛋白、线粒体抗病毒信号蛋白、TBK-1、IκB激酶ε(IKKε)和IFN调节因子3(IRF3))的异位表达所触发的IFN-β基因表达。虽然IFN-β mRNA的稳定性不受影响,但表达IE1的细胞在受到TBK-1或IKKε激活后,其二聚化IRF3和核转位IRF3的水平降低。使用核提取物和凝胶迁移实验,我们可以证明在存在IE1的情况下,IRF3不能有效地结合到IFN-β启动子序列上。总体而言,这些结果表明,HHV-6的IE1蛋白是病毒进入后最早合成的病毒蛋白之一,是IFN-β基因诱导的有效抑制剂,可能有助于促进该病毒对细胞的建立和成功感染。